These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 581016)

  • 1. Effects of two analgesic opiates (methadone and pentazocine) on the serum prolactin levels in breast cancer.
    Rolandi E; Barreca T
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):452-4. PubMed ID: 581016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of methadone and pentazocine on blood levels of prolactin in the human].
    Barreca T; Gallamini A; Gianrossi R; Masturzo P; Murialdo G; Nizzo MC; Rolandi E
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):201-4. PubMed ID: 83873
    [No Abstract]   [Full Text] [Related]  

  • 3. Opiates, prolactin, and the dopamine receptor.
    Tolis G; Dent R; Guyda H
    J Clin Endocrinol Metab; 1978 Jul; 47(1):200-3. PubMed ID: 263291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of prolactin in breast cancer patients.
    Mujagić Z; Mujagić H; Prnjavorac B
    Med Arh; 2005; 59(1):33-5. PubMed ID: 15822682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid-stimulating hormone and prolactin levels in breast cancer.
    Aldinger KA; Schultz PN; Blumenschein GR; Samaan NA
    Arch Intern Med; 1978 Nov; 138(11):1638-41. PubMed ID: 102267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer.
    Lissoni P; Vaghi M; Ardizzoia A; Fumagalli E; Tancini G; Gardani G; Conti A; Maestroni GJ
    Neuro Endocrinol Lett; 2001; 22(1):27-9. PubMed ID: 11335876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
    Pannuti F; Martoni A; Farabegoli G; Piana E
    Chemioterapia; 1985 Apr; 4(2):127-34. PubMed ID: 3159487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
    Maddox PR; Jones DL; Mansel RE
    Br J Cancer; 1992 Mar; 65(3):456-60. PubMed ID: 1558804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of serum prolactin levels in advanced breast cancer.
    Dowsett M; McGarrick GE; Harris AL; Coombes RC; Smith IE; Jeffcoate SL
    Br J Cancer; 1983 Jun; 47(6):763-9. PubMed ID: 6860546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
    Love RR; Rose DR; Surawicz TS; Newcomb PA
    Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
    Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactin and human cancer of the breast. I. Levels of correlation].
    Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?
    Bhatavdekar JM; Patel DD; Karelia NH; Shah NG; Ghosh N; Vora HH; Suthar TP; Balar DB; Doctor SS
    Eur J Surg Oncol; 1994 Apr; 20(2):118-21. PubMed ID: 8181575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline.
    Lissoni P; Vaghi M; Villa S; Bodraska A; Cerizza L; Tancini G; Gardani GS
    Anticancer Res; 2003; 23(1B):733-6. PubMed ID: 12680176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.